Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corp (NQ: SRRK )

5.850 +0.060 (+1.04%)
Streaming Delayed Price Updated: 3:08 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 118,326
Open 5.740
Bid (Size) 5.840 (3)
Ask (Size) 5.850 (2)
Prev. Close 5.790
Today's Range 5.560 - 5.910
52wk Range 4.325 - 13.00
Shares Outstanding 54,291,331
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress
From Scholar Rock, Inc.
Via Business Wire

Performance

YTD
-38.94%
-38.94%
1 Month
-12.16%
-12.16%
3 Month
-31.82%
-31.82%
6 Month
-22.92%
-22.92%
1 Year
+16.53%
+16.53%

More News

Read More
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
From Scholar Rock
Via Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
From Scholar Rock
Via Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony
Via Benzinga
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
From Scholar Rock
Via Business Wire
Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
From Scholar Rock
Via Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
From Scholar Rock
Via Business Wire
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
Via Investor's Business Daily
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Insiders Buying Heska, B. Riley Financial And 2 Other Stocks
Via Benzinga
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
From Scholar Rock
Via Business Wire
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Scholar Rock
Via Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Salesforce To $225? Plus Mizuho Predicts $135 For VMware
Via Benzinga
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
From Scholar Rock
Via Business Wire
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
From Scholar Rock
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.